pki-166
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
EGFR inhibitor
Also potent against ABL1
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1- Mol. weight
- 330.39 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1963502 ↗
Also known as
- 4-phenethylamino-6-(yderoxyl)phenyl-7h-pyrrolo(2,3-d)pyrimidine
- cgp75166
- cgp 75166
- cgp-75166
- cgp-75166
- cgp-75166
- nvp-pki166
- nvp-pki166
- pki166
- pki 166
- pki-166
- pki-166
- pki-166